Amgen – Amgen Stock Is 1% Down So Far At the moment

Shares of Amgen fell 1.57% to $227.62 at 11:39 EST on Friday, following yesterday’s upward pattern. The Nasdaq Stock Market is falling 0.26% to $12,731.30, after 4 consecutive classes in a row of positive aspects. This appears, to date, a considerably tough pattern buying and selling session right now.

Amgen’s final shut was $231.24, 16.41% underneath its 52-week excessive of $264.97.

Amgen’s Gross sales

Amgen’s gross sales development is 6.4% for the current quarter and three.3% for the following. The corporate’s development estimates for the present quarter is a destructive 6.3% and constructive 1% for the following.

Amgen’s Income

12 months-on-year quarterly income development grew by 12%, now sitting on 24.99B for the twelve trailing months.

Amgen’s Stock Yearly Prime and Backside Worth

Amgen’s stock is valued at $227.62 at 11:39 EST, method underneath its 52-week excessive of $264.97 and method above its 52-week low of $177.05.

Amgen’s Transferring Common

Amgen’s value is under its 50-day shifting common of $228.10 and under its 200-day shifting common of $238.25.

Earlier days information about Amgen

Stocks making the most important strikes after the bell: Roku, Amgen & extra. In response to CNBC on Wed Dec 16, “Amgen – Amgen climbed 0.3% after the biotech firm raised its quarterly dividend to $1.76 per share from $1.60 per share.”